8/31
12:42 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $18.00 price target on the stock.
8/30
12:16 pm
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
Medium
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $23.00 price target on the stock.
8/29
04:13 pm
artv
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
Low
Report
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights [Yahoo! Finance]
8/29
04:05 pm
artv
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Low
Report
Artiva Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
8/29
06:03 am
artv
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment [Yahoo! Finance]
Medium
Report
This Biotech IPO Stock Aims to Seize a Multibillion-Dollar Market with Its Innovative Treatment [Yahoo! Finance]
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $23.00 price target on the stock.
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $21.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating and a $21.00 price target on the stock.
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $23.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $23.00 price target on the stock.
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at Wedbush. They set an "outperform" rating and a $18.00 price target on the stock.
8/13
07:54 am
artv
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
Low
Report
Artiva Biotherapeutics, Inc. (NASDAQ: ARTV) is now covered by analysts at TD Cowen. They set a "buy" rating on the stock.
7/20
09:31 am
artv
Is Artiva Biotherapeutics (NASDAQ:ARTV) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
Low
Report
Is Artiva Biotherapeutics (NASDAQ:ARTV) In A Good Position To Deliver On Growth Plans? [Yahoo! Finance]
7/18
07:26 pm
artv
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering [Yahoo! Finance]
High
Report
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering [Yahoo! Finance]
7/18
07:08 pm
artv
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering
High
Report
Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering